Evidently Raises $15M in Series A Funding

Company Name: Evidently
Location: Palo Alto, CA
Industry: AI for Healthcare Workflows

Funding Details:

• Amount: $15M
• Investors: DN Capital (lead), FRAMEWORK, Clear Ventures, Fellows Fund
• Board Addition: Gulsah Wilke, Partner at DN Capital

Purpose of Investment:
The funds will be used to meet growing product demand, expand into population health, and develop clinical research analytics capabilities.

Leadership:

• CEO: Feng Niu
• Chief Product Officer: Kalie Dove-Maguire, MD

Product:
Evidently provides a cognitive AI platform that helps healthcare providers access and utilize clinical data efficiently. Acting as an AI resident, the platform synthesizes information from various sources like external health records and faxes to deliver concise, actionable summaries and real-time decision support.

About the Company:
Evidently’s platform is designed to enhance healthcare delivery by:

• Data Integration: Connecting siloed clinical data for unified access.
• AI-Powered Summaries: Generating concise, actionable insights for clinicians.
• Decision Support: Offering real-time clinical recommendations.
• Reducing Burnout: Automating administrative tasks to free up time for patient care.

Evidently supports healthcare providers in delivering superior patient care while improving operational efficiency and reducing clinician burnout.